Abstract

Many component processes of reward require appropriate serotonin (5HT) and dopamine (DA) neurotransmission within key limbic brain regions. Evidence suggests that dysregulation of 5HT and DA transmission can precipitate reward dysfunction and major depressive disorder (MDD) symptoms in genetically predisposed individuals. Various neurobiological indicators (biomarkers) of MDD have been proposed, including changes in signal transduction pathways, protein phosphorylation, and gene expression in subcortical, reward-related structures. However, these insights have yielded limited clinically relevant benefits for diagnosis, treatment, or prognosis. In addition, clinical application of identified biomarkers is often hindered by multiple factors including disease heterogeneity and symptom variability between patients. Innovative approaches including big data analytics, methodical collaboration between research programs, and reverse-translational strategies are now required to understand if particular biomarkers can be used to predict disease onset and treatment response, to stratify treatments for patient subgroups, and develop novel pharmacotherapies. This review briefly summarizes the predictive value of big data analytics in parsing the neurobiological underpinnings of MDD, with a focus on potential clinically-viable biomarkers for predictive therapies.

Highlights

  • Many component processes of reward require appropriate serotonin (5HT) and dopamine (DA) neurotransmission within key limbic brain regions

  • Investigations into the neurobiology of reward processing suggest that dysregulated neurotransmission and molecular signaling cascades within principal reward-related brain regions are critically involved in major depressive disorder (MDD) pathophysiology.[2,3,4]

  • This analytic framework may serve to bridge the gap between the current status of MDD treatment and individually optimized therapeutic regimens.[6,7,8]

Read more

Summary

Introduction

Many component processes of reward require appropriate serotonin (5HT) and dopamine (DA) neurotransmission within key limbic brain regions.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.